WntResearch AB (NGM: WNT)

Market Cap	5.94M
Revenue (ttm)	n/a
Net Income (ttm)	-44.02M
Shares Out	8.66M
EPS (ttm)	-6.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,263
Open	0.650
Previous Close	0.686
Day's Range	0.650 - 0.686
52-Week Range	0.600 - 17.200
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Feb 7, 2025

About WntResearch AB

WntResearch AB, a biotech company, develops therapies to prevent the metastatic process. The company develops Foxy-5, a peptide, which is in Phase II clinical trials that reduced the risk of metastasis in patients with colon cancer. It is also developing Box-5, a WNT5A antagonist for the treatment of malignant melanoma, and pancreatic and gastric cancer. The company was incorporated in 2007 and is based in Lund, Sweden.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2007
• Employees: 2
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: WNT